Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease
Yask Gupta, David J. Friedman, Michelle Mcnulty, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
APOL1 genotyping is incomplete without testing for the protective M1 modifier p.N264K variant
Rasheed Gbadegesin, Elena Martinelli, Yask Gupta, et al.
Glomerular Diseases (2024)
Open Access | Times Cited: 6
From Gene to Clinic: The Role of APOL1 in Focal Segmental Glomerulosclerosis
Charlotte Delrue, Marijn M. Speeckaert
Sclerosis (2025) Vol. 3, Iss. 1, pp. 6-6
Open Access
Kidney dysfunction and associated factors among adults living with human immuno-deficiency virus in Africa: a systematic review and meta-analysis
Worku Chekol Tassew, Agerie Mengistie Zeleke, Yeshiwas Ayale Ferede, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Genome-Wide Polygenic Risk Score for CKD in Individuals with APOL1 High-Risk Genotypes
Ha My T. Vy, Steven G. Coca, Ashwin Sawant, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 19, Iss. 3, pp. 374-376
Open Access | Times Cited: 6
Defining Risk in APOL1-Associated Kidney Disease: The Story is Evolving!
Ashima Gulati, Marva Moxey‐Mims
American Journal of Kidney Diseases (2024) Vol. 84, Iss. 3, pp. 388-391
Closed Access | Times Cited: 1
A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure
Matthew Leong, Tiane Dai, Lili Tong, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Local Inflammation But Not Kidney Cell Infection Associated with High APOL1 Expression in COVID-Associated Nephropathy
Jane Nguyen, Zhenzhen Wu, José Agudelo, et al.
Kidney360 (2023) Vol. 4, Iss. 12, pp. 1757-1762
Open Access | Times Cited: 2
African-Colombian woman with preeclampsia and high-risk APOL1 genotype: A case report
Carlos Durán, Juan David Gutiérrez-Medina, Jacobo Triviño Arias, et al.
Medicine (2024) Vol. 103, Iss. 44, pp. e40284-e40284
Open Access
Omics Studies in CKD: Diagnostic Opportunities and Therapeutic Potential
Merita Rroji, Goce Spasovski
PROTEOMICS (2024)
Closed Access
Host Inflammatory Response in Viral Lower Respiratory Tract Infections: Friend or Foe?
Hannah Moir
Respiratory The American Medical Journal (2023), pp. 26-35
Open Access | Times Cited: 1
Inaxapline as a potential therapy for APOL1-associated nephropathy
Konrad Lang, Tobias Hermle
Deleted Journal (2024) Vol. 19, Iss. 3, pp. 184-186
Closed Access
Page 1

Scroll to top